Back

A Novel Susceptibility Locus in NFASC Highlights Oligodendrocytes and Myelination in Progressive Supranuclear Palsy Pathology

Garcia-Gonzalez, P.; Rodrigo Lara, H.; Compta, Y.; Fernandez, M.; van der Lee, S. J.; de Rojas, I.; Saiz, L.; Painous, C.; Camara, A.; Munoz, E.; Marti, M. J.; Valldeoriola, F.; Puerta, R.; Illan-Gala, I.; Pagonabarraga, J.; Dols-Icardo, O.; Kulisevsky, J.; Fortea, J.; Lleo, A.; Olive, C.; de Boer, S. C. M.; Hulsman, M.; Pijnenburg, Y. A. L.; Diaz Belloso, R.; Munoz-Delgado, L.; Buiza Rueda, D.; Gomez-Garre, P.; Aldecoa, I.; Aragones, G.; Hernandez Vara, J.; Mendioroz, M.; Perez-Tur, J.; Visser, P. J.; den Braber, A.; Papma, J. M.; Martin Montes, A.; Blazquez-Folch, J.; Miguel, A.; Garcia-Guti

2024-06-21 genetic and genomic medicine
10.1101/2024.06.21.24309279 medRxiv
Show abstract

We conducted the largest PSP GWAS of the Iberian population to date (522 cases from 22 Spanish and Portuguese institutions). We independently replicated seven known PSP risk variants, and unveiled a novel locus in NFASC/CNTN2 after meta-analysing our results with a newly available Dutch cohort and publicly available summary statistics. These findings highlight the importance of neuron-oligodendrocyte interactions in PSP etiopathology.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.